Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity
Language English Country Turkey Media print-electronic
Document type Journal Article
PubMed
36247531
PubMed Central
PMC9727721
DOI
10.4274/tjh.galenos.2022.2022.0290
Knihovny.cz E-resources
- Keywords
- Myelodysplastic syndrome, Plasma proteome, Proteomics,
- MeSH
- Humans MeSH
- Myelodysplastic Syndromes * diagnosis MeSH
- Proteomics * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
See more in PubMed
Ogawa S. Genetic basis of myelodysplastic syndromes. Proc Japan Acad Ser B Phys Biol Sci. 2020;96:107–121. PubMed PMC
Nagata Y, Maciejewski JP. The functional mechanisms of mutations in myelodysplastic syndrome. Leukemia. 2019;33:2779–2794. PubMed PMC
Májek P, Reicheltová Z, Suttnar J, Cermák J, Dyr JE. Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia. Proteome Sci. 2011;9:64. PubMed PMC
Májek P, Reicheltová Z, Suttnar J, Cermák J, Dyr JE. Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome. Proteome Sci. 2012;10:31. PubMed PMC
Majek P, Riedelova-Reicheltova Z, Suttnar J, Pecankova K, Cermak J, Dyr JE. Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2. Dis Markers. 2014;2014:178709. PubMed PMC
Májek P, Riedelová-Reicheltová Z, Suttnar J, Pečánková K, Cermák J, Dyr JE. Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome. Proteome Sci. 2013;11:14. PubMed PMC
Majek P, Pecankova K, Cermak J, Gasova Z, Dyr JE. Retinol binding protein 4 plasma level in myelodysplastic syndrome subgroups. Int J Lab Hematol. 2015;37:e127–128. PubMed
Majek P, Pecankova K, Cermak J, Gasova Z, Prochazka B, Dyr JE. Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes. Cancer Biomark. 2017;20:637–639. PubMed
